Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Couldn't they just do a 20 to 1 reverse split and issue the ceo preferred shares so he remains in control of the company as they issue more shares to raise cash? I believe I've seen that before.
Does the rule about being current mean you can't convert shares or you can't sell them? If the rule means you can't convert them than vndm is probably jut selling what it has left.
maxm on the bid too
That was just per OTC markets.
Thanks, still very low. In one of my posts I mentioned the 196 number was from feb 17th and the other one I didn't.
o/s is 458 mil, that's the one that matters in case you didn't know.
Haha, Alert! This guy just did his research and thinks the market cap for this company is 20k, take him seriously!
Haha, dude you lost that one, find me a sub penny stock with less than 200 mil O/S that has a brand new, tv straight to your phone app that is advertising in times square.
Take the company tweets about dilution being over for what you will, this one is going to run, imo.
O/S 196 mil as of Feb 17th this year,
https://www.otcmarkets.com/stock/OTTV/profile
There have also been .001 ish runners into the close for 300% gains the last few fridays based of tweets, if I'm remembering correctly and this one is much better than the others. Much lower O/S.
Plus the company said they're doing an ad in times square for their new tv app? Pretty good stuff for a sub penny stock.
I had no idea the O/S was that low, even if it's a little bit higher now.
I really don't know I just read it on the board here, but their twitter account seemed to suggest something coming on monday, imo.
I thought the ad was coming on monday? Thus their twitter account suggesting we judge whether or not the dilluters are gone by checking out the action on monday?
BOOM vfin gone
I didn't know this thank you.
Yeah also on the wall at .08, hard to imagine anyone trying to sell $70,000 of a penny stock at one time without breaking it up. It could be a beginner who doesn't know any better but I kind of doubt it.
They have partially, we are waiting on the 8k to make it official. Gl
Haha.
Wow, haha. Hmm, this is why you need DD and charts. Your two complaints are about a company that no longer exists.
Yes, that's what I was saying, as FIN85 pointed out that would put us around .84 a share. Everyone do you own DD and make your own comparisons though. I only did 5 mins of DD on that company.
What are you talking about? It's a attempt to compare a similar stock to see what we might be valued at and we come out at around .84 pps?
And you're right, this one is thinner and more susceptible to big moves.
Right.
Here is a company that is somewhat similar to us in that it's on otc stock that has orphan designation and one drug in phase two clinical trials as well as others in the pipeline using the same type of treatment (this after 5 mins of DD so look into it yourself).
They also have some cash on hand as we expect to.
http://www.otcmarkets.com/stock/PMCB/profile
http://pharmacyte.com/research-development/
They have about 10 time the number of shares and are trading at .089 pps.
The new CEO is getting 61 mil shares, the new O/S will be around 93 million, still low. An R/S wouldn't necessarily be a bad thing here, but like I said it seems unlikely.
There may be some uncertainty about, for instance, they may have just finished a clinical trial for Prolanta.
https://clinicaltrials.gov/ct2/show/results/NCT02534922
Maybe it didn't go so well? But why would they be going public after a failed trial, all of their drugs seem to be related to this same type of cancer treatment.
Some might be worried about a potential R/S, but the share structure is pretty low and the new ceo owns 60 mil so that seems unlikely (though possible?)
People want details. I'm just hoping the trial went well. Prolanta has orphan drug designation so that means:
- Seven-year marketing exclusivity to the first sponsor obtaining FDA approval of a designated drug
- Tax credit equal to 50% of clinical investigation expenses
- Exemption/Waiver of PDUFA application (filing) fees
- Assistance in the drug development process
- Orphan Products Grant funding
They've already been able to get millions in financing so there must be some promise there.
Yeah.
I doubled down as well, sell half at double and ride free shares.
Yeah I know that's what I was saying, he's there to cover possibly using vndm to scare shares.
Yeah I mean it makes since ASCM is right on the bid below him, I didn't know you could actually do that.
Have you guys that have been here for a while seen VNDM on the ask like they are this morning? Why would they be there at all? Is that ever used as a tactic to get shares? I've seen that with VFIN but never VNDM.
ARXS is here boys and he's hungry.
KRED KonaRed had a big February, .065 OTCQB 148 mil O/S
Fueled by dynamic growth in sales of Ready to Drink Cold Brew Coffees, during February 2017 KonaRed's sales surpassed $220,000, which compares to $43,000 for the same period in 2016.
KonaRed's President and COO Kyle Redfield commented, "Growth of our shipped sales during the start of 2017 have been impressive and exceeded our internal targets. We have been rapidly growing our customer base nationwide, and are only at the beginning of major sales increases. With the customer base we already have coupled with retail commitments set to hit shelves this summer, we are going to continue to experience rapid growth in our sales."
Mr. Redfield continued, "We haven't yet come into the summer months where cold beverage sales spike, so we know the largest sales months are ahead of us. The Cold Brew Coffee category is primed to have its biggest year yet, and continues to prove out as a major growth trend in food and beverage. We have now built a consumer base with our award winning RTD cold brew coffee products that has us positioned as a leader in the category. Overall this is a great time in our company, and we feel confident in our ability to deliver strong results in 2017
KOLOA, Hawaii, January 24, 2017 – KonaRed Corporation (OTCQB: KRED), manufacturers of premium Hawaiian Cold Brew Coffee and Whole Bean Coffee products and the pioneer of the USA coffee fruit category, today announced record growth in the 4th quarter of 2016 which projects to an upward trend of revenue growth for 2017.
During the year ended December 31, 2016, KonaRed's comparative total revenue grew by 98% to $1.26mm for 2016 from $635,503 for 2015. Total revenue for the comparative 4th quarter periods grew by 422% to approximately $470K from approximately $90K, including a one-time license fee of $200K in Q4 2016. KonaRed's new line of Cold Brew Coffees accounted for 68% of product sales for Q4 of 2016 and 49% for the full year. During 2016, Cold Brew sales increased from a starting point of $22,000 in Q1 to a total of $613,200 by year-end.
KonaRed's CEO Shaun Roberts commented, "We made big strides in 2016 with our award winning Cold Brew Coffees and new line extensions that are driving our revenue growth. Our new Bag in the Box Cold Brew Coffee is now available at Costco Hawaii and we’ve been methodically expanding our customer base. Recent successes have included additional distribution in Safeway, Bristol Farms and 7-11 Stores. Revenues are up and we’ve been diligently working to reduce expenses and focus in on our path to profitability.”
KonaRed is continuing to rapidly bring on large new customers such as Publix with 1,100 stores in the southeastern United States and new Safeway and Whole Foods Market regions. The Company’s award winning Cold Brew Coffees are becoming established as leaders in the fast growing Cold Brew Coffee category.
Average quarterly sales growth for KonaRed's Cold Brew Coffees during 2016 was over
160% and its Cold Brew Coffee sales are expected to accelerate and exceed an average
quarterly growth rate of approximately 65% during 2017, with significant peaks during the mid-year summer periods. If trends continue as expected, conservatively, Cold Brew Coffee sales should grow by approximately 5 times 2016 sales to approximately $3.0 million in 2017 which would increase total revenue to approximately 3 times 2016 total revenue.
To fuel the growth, the company completed a $1.14mm strategic investment from the PCF Holdings Group and recently added long time beverage industry icon, James S. Tonkin, to the Board of Directors. Jim is the founder and President of HealthyBrandBuilders and will be a key advisor to the company as we continue our revenue growth.
Jim commented: "Timing is everything with new product trends and KonaRed's Cold Brew Coffee is making a big mark - right now! I'm looking forward to contributing to KonaRed's growth at this transition time for the Company as I see the Company lining itself up to be a definitive category leader."
KRED KonaRed had a big February, .065 OTCQB 148 mil O/S
Fueled by dynamic growth in sales of Ready to Drink Cold Brew Coffees, during February 2017 KonaRed's sales surpassed $220,000, which compares to $43,000 for the same period in 2016.
KonaRed's President and COO Kyle Redfield commented, "Growth of our shipped sales during the start of 2017 have been impressive and exceeded our internal targets. We have been rapidly growing our customer base nationwide, and are only at the beginning of major sales increases. With the customer base we already have coupled with retail commitments set to hit shelves this summer, we are going to continue to experience rapid growth in our sales."
Mr. Redfield continued, "We haven't yet come into the summer months where cold beverage sales spike, so we know the largest sales months are ahead of us. The Cold Brew Coffee category is primed to have its biggest year yet, and continues to prove out as a major growth trend in food and beverage. We have now built a consumer base with our award winning RTD cold brew coffee products that has us positioned as a leader in the category. Overall this is a great time in our company, and we feel confident in our ability to deliver strong results in 2017
KOLOA, Hawaii, January 24, 2017 – KonaRed Corporation (OTCQB: KRED), manufacturers of premium Hawaiian Cold Brew Coffee and Whole Bean Coffee products and the pioneer of the USA coffee fruit category, today announced record growth in the 4th quarter of 2016 which projects to an upward trend of revenue growth for 2017.
During the year ended December 31, 2016, KonaRed's comparative total revenue grew by 98% to $1.26mm for 2016 from $635,503 for 2015. Total revenue for the comparative 4th quarter periods grew by 422% to approximately $470K from approximately $90K, including a one-time license fee of $200K in Q4 2016. KonaRed's new line of Cold Brew Coffees accounted for 68% of product sales for Q4 of 2016 and 49% for the full year. During 2016, Cold Brew sales increased from a starting point of $22,000 in Q1 to a total of $613,200 by year-end.
KonaRed's CEO Shaun Roberts commented, "We made big strides in 2016 with our award winning Cold Brew Coffees and new line extensions that are driving our revenue growth. Our new Bag in the Box Cold Brew Coffee is now available at Costco Hawaii and we’ve been methodically expanding our customer base. Recent successes have included additional distribution in Safeway, Bristol Farms and 7-11 Stores. Revenues are up and we’ve been diligently working to reduce expenses and focus in on our path to profitability.”
KonaRed is continuing to rapidly bring on large new customers such as Publix with 1,100 stores in the southeastern United States and new Safeway and Whole Foods Market regions. The Company’s award winning Cold Brew Coffees are becoming established as leaders in the fast growing Cold Brew Coffee category.
Average quarterly sales growth for KonaRed's Cold Brew Coffees during 2016 was over
160% and its Cold Brew Coffee sales are expected to accelerate and exceed an average
quarterly growth rate of approximately 65% during 2017, with significant peaks during the mid-year summer periods. If trends continue as expected, conservatively, Cold Brew Coffee sales should grow by approximately 5 times 2016 sales to approximately $3.0 million in 2017 which would increase total revenue to approximately 3 times 2016 total revenue.
To fuel the growth, the company completed a $1.14mm strategic investment from the PCF Holdings Group and recently added long time beverage industry icon, James S. Tonkin, to the Board of Directors. Jim is the founder and President of HealthyBrandBuilders and will be a key advisor to the company as we continue our revenue growth.
Jim commented: "Timing is everything with new product trends and KonaRed's Cold Brew Coffee is making a big mark - right now! I'm looking forward to contributing to KonaRed's growth at this transition time for the Company as I see the Company lining itself up to be a definitive category leader."
In fingers email from the CEO he said "We will get financing before the CSE listing and complete a final financing upon listing, if necessary"
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129268738
ARXS back in play, I think we move back up again now.
ARXS back on bid
It has to be a loading wall, no one could be that stupid to put up 100k on the ask at the same time.
bmak almost done, very close now, moving up with every bid to cover and moving off the ask with small slaps then right back down. I don't know but that seems like an algorithm almost done to me.